Turner Andrew L

Director at STRM; Director at Actavis plc; Director at WATSON PHARMACEUTICALS INC

Sold, on record
$4.7M
Dollars the filings state
Form 4 sales
14
Latest Jan 20, 2015
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale WATSON PHARMACEUTICALS INCUnusual
    May 29 2012

    Sold 20,000 shares at $73.59 ($1.5M)

    Turner Andrew L, Director

    Sold 76.7% of holdings ($1.9M position)6,064 shares left4.4x usual sizeFiling

  2. 2 Form 4 sale WATSON PHARMACEUTICALS INCUnusual
    Mar 4 +279 days

    Sold 2,500 shares at $85.76 ($214k)

    Turner Andrew L, Director

    Sold 41.2% of holdings ($520k position)3,564 shares left0.4x usual sizeFiling

  3. 3 Form 4 sale Actavis plcUnusual
    Nov 4 +245 days

    Sold 2,677 shares at $156.48 ($419k)

    Turner Andrew L, Director

    Sold 49.2% of holdings ($851k position)2,764 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale Actavis plcUnusual
    Nov 22 +18 days

    Sold 2,500 shares at $163.45 ($409k)

    Turner Andrew L, Director

    Sold 90.4% of holdings ($452k position)264 shares leftFiling

  5. 5 Form 4 sale Actavis plcUnusual
    Dec 5 +13 days

    Sold 264 shares at $162.43 ($43k)

    Turner Andrew L, Director

    Sold 100% of holdings ($43k position)0 shares leftFiling

  6. 6 Form 4 sale STRMPlan not stated
    Dec 27 +22 days

    Sold 25,000 shares at $6.63 ($166k)

    Turner Andrew L, Director

    Sold 20.4% of holdings ($812k position)97,527 shares leftFirst sale on recordFiling

  7. 7 Form 4 sale STRMPlan not stated
    Sep 23 +270 days

    Sold 17,567 shares at $3.83 ($67k)

    Turner Andrew L, Director

    Sold 16.4% of holdings ($410k position)89,513 shares leftFiling

  8. 8 Form 4 sale STRMUnusual
    Jan 20 +119 days

    Sold 24,960 shares at $3.54 ($88k)

    Turner Andrew L, Director

    Sold 27.9% of holdings ($317k position)64,553 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (14)

Form 144 notices and Form 4 sales by Turner Andrew L
Source
Jan 20, 2015STRMDirectorForm 4 sale24,960$88k27.9%UnusualSEC
Sep 23, 2014STRMDirectorForm 4 sale17,567$67k16.4%Plan not statedSEC
Dec 27, 2013STRMDirectorForm 4 sale25,000$166k20.4%Plan not statedSEC
Dec 5, 2013Actavis plcDirectorForm 4 sale264$43k100.0%UnusualSEC
Nov 22, 2013Actavis plcDirectorForm 4 sale2,500$409k90.4%UnusualSEC
Nov 4, 2013Actavis plcDirectorForm 4 sale2,677$419k49.2%UnusualSEC
Mar 4, 2013WATSON PHARMACEUTICALS INCDirectorForm 4 sale2,500$214k41.2%UnusualSEC
May 29, 2012WATSON PHARMACEUTICALS INCDirectorForm 4 sale20,000$1.5M76.7%UnusualSEC
Nov 15, 2011WATSON PHARMACEUTICALS INCDirectorForm 4 sale10,000$658k75.9%UnusualSEC
Sep 14, 2011WATSON PHARMACEUTICALS INCDirectorForm 4 sale4,000$264k55.7%UnusualSEC
Aug 15, 2011WATSON PHARMACEUTICALS INCDirectorForm 4 sale1,000$65k12.2%Plan not statedSEC
Jun 11, 2010WATSON PHARMACEUTICALS INCDirectorForm 4 sale5,000$213k50.0%UnusualSEC
Mar 15, 2010WATSON PHARMACEUTICALS INCDirectorForm 4 sale5,000$206k50.0%UnusualSEC
Dec 10, 2009WATSON PHARMACEUTICALS INCDirectorForm 4 sale10,001$382k66.7%UnusualSEC